Brian Conway

4.7k total citations · 1 hit paper
51 papers, 3.5k citations indexed

About

Brian Conway is a scholar working on Infectious Diseases, Virology and Hepatology. According to data from OpenAlex, Brian Conway has authored 51 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 25 papers in Virology and 21 papers in Hepatology. Recurrent topics in Brian Conway's work include HIV Research and Treatment (25 papers), HIV/AIDS drug development and treatment (24 papers) and Hepatitis C virus research (21 papers). Brian Conway is often cited by papers focused on HIV Research and Treatment (25 papers), HIV/AIDS drug development and treatment (24 papers) and Hepatitis C virus research (21 papers). Brian Conway collaborates with scholars based in Canada, United States and Australia. Brian Conway's co-authors include Douglas D. Richman, John W. Mellors, Daniel R. Kuritzkes, Bonaventura Clotet, Victoria A. Johnson, Françoise Brun‐Vézinet, Lisa M. Demeter, Jean‐Pierre Routy, Clive Loveday and Scott M. Hammer and has published in prestigious journals such as New England Journal of Medicine, JAMA and The Journal of Immunology.

In The Last Decade

Brian Conway

48 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antiretroviral-Drug Resistance among Patients Recently Infected with HIV

2002 878 citations Jean‐Pierre Routy, John W. Mellors et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Conway Canada	20	3.1k	2.9k	493	211	210	51	3.5k
Daniela Moïsi Canada	27	2.4k 0.8×	2.2k 0.8×	654 1.3×	245 1.2×	102 0.5×	68	2.6k
Clive Loveday United Kingdom	33	3.6k 1.2×	3.2k 1.1×	844 1.7×	209 1.0×	404 1.9×	93	4.3k
Hui Xing China	31	2.8k 0.9×	2.4k 0.8×	1.4k 2.8×	170 0.8×	152 0.7×	192	3.4k
Charles J. Gonzalez United States	18	2.6k 0.8×	2.3k 0.8×	658 1.3×	348 1.6×	199 0.9×	34	3.4k
Kurt Hertogs United States	40	3.7k 1.2×	3.5k 1.2×	554 1.1×	568 2.7×	275 1.3×	84	4.3k
Brian Wynhoven Canada	21	1.7k 0.5×	1.5k 0.5×	448 0.9×	281 1.3×	144 0.7×	30	2.1k
Annemarie M. J. Wensing Netherlands	29	1.9k 0.6×	1.6k 0.6×	578 1.2×	262 1.2×	119 0.6×	99	2.6k
Bernard Masquelier France	30	2.1k 0.7×	1.9k 0.7×	399 0.8×	181 0.9×	105 0.5×	85	2.3k
Ralph DeMasi United States	25	2.6k 0.8×	2.3k 0.8×	752 1.5×	422 2.0×	520 2.5×	82	3.7k
Teri Liegler United States	32	2.5k 0.8×	2.5k 0.9×	792 1.6×	269 1.3×	89 0.4×	77	3.3k

Countries citing papers authored by Brian Conway

Since Specialization

Citations

This map shows the geographic impact of Brian Conway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Conway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Conway more than expected).

Fields of papers citing papers by Brian Conway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Conway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Conway. The network helps show where Brian Conway may publish in the future.

Co-authorship network of co-authors of Brian Conway

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Conway. A scholar is included among the top collaborators of Brian Conway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Conway. Brian Conway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Conway, Brian, et al.. (2024). GRAND PLAN: Safety and Efficacy of Glecaprevir/Pibrentasvir for the Treatment of Hepatitis C Virus Infection Among People Initially Disengaged From Health Care Who Use Drugs—A Systematic Multidisciplinary Approach. Open Forum Infectious Diseases. 11(3). ofad638–ofad638. 1 indexed citations

Martinez, Anthony, et al.. (2023). Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017–2021. Harm Reduction Journal. 20(1). 142–142.

Traeger, Michael W., Lakshmi Manoharan, Niklas Luhmann, et al.. (2023). Determining reinfection rates by hepatitis C testing interval among key populations: A systematic review and meta‐analysis. Liver International. 43(12). 2625–2644. 2 indexed citations

Conway, Brian, et al.. (2020). COVID-19 in Homeless Populations: Unique Challenges and Opportunities. Future Virology. 15(6). 331–334. 22 indexed citations

Conway, Brian, et al.. (2018). A167 AN ANALYSIS OF TREATMENT UPTAKE AND EFFICACY USING ALL-ORAL DIRECT-ACTING ANTIVIRAL (DAA) THERAPY IN HCV-INFECTED PEOPLE WHO INJECT DRUGS (PWID). Journal of the Canadian Association of Gastroenterology. 1(suppl_1). 289–290. 1 indexed citations

Conway, Brian, et al.. (2017). Analysis of Adherence to AllOral HCV Therapy in a Cohort of People who Inject Drugs (PWID). 3(1). 1 indexed citations

Conway, Brian, et al.. (2017). Repeated Spontaneous Clearance of Hepatitis C Virus Infection in the Setting of Long-Term Non-Progression of HIV Infection. Infectious Disease Reports. 9(3). 7142–7142. 3 indexed citations

Conway, Brian, et al.. (2016). Community-Based Infectious Disease Clinics:A Tool Of Engagement For VulnerablePopulations. 2(1). 2 indexed citations

Clifford, David B., David M. Simpson, Stephen Brown, et al.. (2011). A Randomized, Double-Blind, Controlled Study of NGX-4010, a Capsaicin 8% Dermal Patch, for the Treatment of Painful HIV-Associated Distal Sensory Polyneuropathy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 59(2). 126–133. 73 indexed citations

10.

Conway, Brian. (2007). The Role of Adherence to Antiretroviral Therapy in the Management of HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 45(Supplement 1). S14–S18. 86 indexed citations

11.

Alter, Galit, George Hatzakis, Christos Tsoukas, et al.. (2003). Longitudinal Assessment of Changes in HIV-Specific Effector Activity in HIV-Infected Patients Starting Highly Active Antiretroviral Therapy in Primary Infection. The Journal of Immunology. 171(1). 477–488. 41 indexed citations

12.

Hirsch, Martin, Françoise Brun‐Vézinet, Bonaventura Clotet, et al.. (2003). Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society–USA Panel. Clinical Infectious Diseases. 37(1). 113–128. 387 indexed citations

13.

Salomón, Horacio, Mark A. Wainberg, Bluma Brenner, et al.. (2000). Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. AIDS. 14(2). F17–F23. 180 indexed citations

14.

Montessori, Valentina, Danielle Rouleau, Janet Raboud, et al.. (2000). Clinical characteristics of primary HIV infection in injection drug users. AIDS. 14(12). 1868–1870. 2 indexed citations

15.

Brenner, Bluma, Mark A. Wainberg, Horacio Salomón, et al.. (2000). Resistance to antiretroviral drugs in patients with primary HIV-1 infection. International Journal of Antimicrobial Agents. 16(4). 429–434. 53 indexed citations

16.

Hirsch, Martin, Brian Conway, Richard T. D'Aquila, et al.. (1998). Antiretroviral Drug Resistance Testing in Adults With HIV Infection. JAMA. 279(24). 1984–1984. 475 indexed citations

17.

Hogg, Robert S., Benita Yip, Chris Sherlock, et al.. (1998). Antiviral effect of double and triple drug combinations amongst HIV-infected adults. AIDS. 12(3). 279–284. 77 indexed citations

18.

Hall, David B., Peter Reiss, David A. Cooper, et al.. (1998). Induction–maintenance antiretroviral therapy. AIDS. 12(7). F41–F44. 64 indexed citations

19.

Mitsuyasu, Ronald T., Paul R. Skolnik, Brian Conway, et al.. (1998). Activity of the soft gelatin formulation of saquinavir in combination therapy in antiretroviral-naive patients. AIDS. 12(11). F103–F109. 39 indexed citations

20.

Montaner, Julio, Carlos Zala, Brian Conway, et al.. (1997). A Pilot Study of Hydroxyurea among Patients with Advanced Human Immunodeficiency Virus (HIV) Disease Receiving Chronic Didanosine Therapy: Canadian HIV Trials Network Protocol 080. The Journal of Infectious Diseases. 175(4). 801–806. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact